Comparison of Baseline Values and Intermediate and Long-Term Changes in Clinical Outcome Measures in Intervention and Control Practice Patients
| Control Practice (n = 359 Patients) | Intervention Practice (n = 368 Patients) | |||||
|---|---|---|---|---|---|---|
| Clinical Parameters | Baseline | 18 Mo | 36 Mo | Baseline | 18 Mo | 36 Mo |
| HbA1c, mean (SD), % | 7.9 (2.2) | 7.7 (1.9) | 7.8 (2.0) | 7.9 (2.1) | 7.4 (1.6)a | 7.4 (1.9)b |
| ≤7.5 %, No. (%) | 134 (56) | 170 (60) | 165 (59) | 164 (55) | 189 (66) | 146 (68)c |
| >7.5%, No. (%) | 106 (44) | 114 (40) | 117 (41) | 132 (45) | 96 (34) | 69 (32)c |
| Systolic/diastolic blood pressure, mean | 138 (18)/ | 139 (16)/ | 140 (17)/ | 135 (16)/ | 135 (14)/ | 135 (16)/ |
| (SD), mm Hg | 81 (10) | 80 (9) | 79 (10) | 79 (8) | 78 (9) | 78 (9) |
| ≤40 mm Hg, No. (%) | 208 (64) | 198 (59) | 178 (57) | 257 (71) | 222 (69)c | 171 (69)c |
| >140 mm Hg, No. (%) | 116 (36) | 140 (41) | 134 (43) | 107 (29) | 101 (31)c | 76 (31)c |
| LDL cholesterol, mean (SD), mg/dL | 101 (36) | 99 (38) | 97 (32) | 105 (33) | 95 (32) | 99 (36)a |
| ≤100 mg/dL, No. (%) | 64 (52) | 141 (57) | 136 (59) | 94 (46) | 128 (61) | 91 (57) |
| >100 mg/dL, No. (%) | 60 (48) | 106 (43) | 94 (41) | 109 (54) | 81 (39) | 68 (43) |
| HDL cholesterol, mean (SD), mg/dL | 50 (13.3) | 51 (13.4) | 50 (13.3) | 50 (12.7) | 50 (13.6) | 52 (13.9)a |
| Total cholesterol, mean (SD), mg/dL | 176 (39.7) | 177 (42.5) | 170 (38.1) | 182 (38.1) | 171 (37.7) | 176 (39.1) |